APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antiretroviral Agent

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Antiretroviral Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025197 pages

Choose your research edition.

Industry ResearchAntiretroviral Agent Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Antiretroviral Agent Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Antiretroviral Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antiretroviral Agent Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Antiretroviral Agent Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Antiretroviral Agent market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Antiretroviral Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antiretroviral Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antiretroviral Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Antiretroviral Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antiretroviral Agent include Boehringer Ingelheim, Bristol-Myers Squibb, Genentech, Gilead Sciences, Merck Sharp and Dohme, ViiV Healthcare, AbbVie, GlaxoSmithKline and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antiretroviral Agent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antiretroviral Agent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antiretroviral Agent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antiretroviral Agent market size, projected growth trends, production technologies, key applications, and end-use industries.

Antiretroviral Agent Segment by Company

Boehringer Ingelheim

Bristol-Myers Squibb

Genentech

Gilead Sciences

Merck Sharp and Dohme

ViiV Healthcare

AbbVie

GlaxoSmithKline

Pfizer

Mylan

Janssen Pharmaceuticals

Antiretroviral Agent Segment by Type

Fusion Inhibitors

Entry Inhibitors—CCR5 Co-Receptor Antagonist

Nucleoside Reverse Transcriptase Inhibitors

Non-Nucleoside Reverse Transcriptase Inhibitors

Protease Inhibitors

HIV Integrase Strand Transfer Inhibitors

Others

Antiretroviral Agent Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Others

Antiretroviral Agent Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiretroviral Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antiretroviral Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiretroviral Agent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antiretroviral Agent market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antiretroviral Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Antiretroviral Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Antiretroviral Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Antiretroviral Agent Industry Trends Table 2. Antiretroviral Agent Industry Drivers Table 3. Antiretroviral Agent Industry Opportunities and Challenges Table 4. Antiretroviral Agent Industry Restraints Table 5. Global Antiretroviral Agent Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Antiretroviral Agent Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Antiretroviral Agent Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Antiretroviral Agent Sales Market Share by Manufacturers Table 9. Global Antiretroviral Agent Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Antiretroviral Agent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Antiretroviral Agent Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Antiretroviral Agent Manufacturers, Product Type & Application Table 13. Global Antiretroviral Agent Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Antiretroviral Agent by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Fusion Inhibitors Table 17. Major Manufacturers of Entry Inhibitors—CCR5 Co-Receptor Antagonist Table 18. Major Manufacturers of Nucleoside Reverse Transcriptase Inhibitors Table 19. Major Manufacturers of Non-Nucleoside Reverse Transcriptase Inhibitors Table 20. Major Manufacturers of Protease Inhibitors Table 21. Major Manufacturers of HIV Integrase Strand Transfer Inhibitors Table 22. Major Manufacturers of Others Table 23. Global Antiretroviral Agent Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Antiretroviral Agent Sales by Type (2021-2026) & (K Units) Table 25. Global Antiretroviral Agent Sales by Type (2027-2032) & (K Units) Table 26. Global Antiretroviral Agent Sales Market Share by Type (2021-2026) Table 27. Global Antiretroviral Agent Sales Market Share by Type (2027-2032) Table 28. Global Antiretroviral Agent Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 29. Global Antiretroviral Agent Revenue by Type (2021-2026) & (K Units) Table 30. Global Antiretroviral Agent Revenue by Type (2027-2032) & (K Units) Table 31. Global Antiretroviral Agent Revenue Market Share by Type (2021-2026) Table 32. Global Antiretroviral Agent Revenue Market Share by Type (2027-2032) Table 33. Major Manufacturers of Retail Pharmacies Table 34. Major Manufacturers of Online Pharmacies Table 35. Major Manufacturers of Hospital Pharmacies Table 36. Major Manufacturers of Others Table 37. Global Antiretroviral Agent Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Antiretroviral Agent Sales by Application (2021-2026) & (K Units) Table 39. Global Antiretroviral Agent Sales by Application (2027-2032) & (K Units) Table 40. Global Antiretroviral Agent Sales Market Share by Application (2021-2026) Table 41. Global Antiretroviral Agent Sales Market Share by Application (2027-2032) Table 42. Global Antiretroviral Agent Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 43. Global Antiretroviral Agent Revenue by Application (2021-2026) & (K Units) Table 44. Global Antiretroviral Agent Revenue by Application (2027-2032) & (K Units) Table 45. Global Antiretroviral Agent Revenue Market Share by Application (2021-2026) Table 46. Global Antiretroviral Agent Revenue Market Share by Application (2027-2032) Table 47. Global Antiretroviral Agent Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 48. Global Antiretroviral Agent Sales by Region (2021-2026) & (K Units) Table 49. Global Antiretroviral Agent Sales Market Share by Region (2021-2026) Table 50. Global Antiretroviral Agent Sales Forecasted by Region (2027-2032) & (K Units) Table 51. Global Antiretroviral Agent Sales Forecasted Market Share by Region (2027-2032) Table 52. North America Antiretroviral Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. North America Antiretroviral Agent Sales by Country (2021-2026) & (K Units) Table 54. North America Antiretroviral Agent Sales by Country (2027-2032) & (K Units) Table 55. Europe Antiretroviral Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Europe Antiretroviral Agent Sales by Country (2021-2026) & (K Units) Table 57. Europe Antiretroviral Agent Sales by Country (2027-2032) & (K Units) Table 58. Asia Pacific Antiretroviral Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. Asia Pacific Antiretroviral Agent Sales by Country (2021-2026) & (K Units) Table 60. Asia Pacific Antiretroviral Agent Sales by Country (2027-2032) & (K Units) Table 61. South America, Middle East and Africa Antiretroviral Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 62. South America, Middle East and Africa Antiretroviral Agent Sales by Country (2021-2026) & (K Units) Table 63. South America, Middle East and Africa Antiretroviral Agent Sales by Country (2027-2032) & (K Units) Table 64. Global Antiretroviral Agent Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global Antiretroviral Agent Revenue by Region (2021-2026) & (US$ Million) Table 66. Global Antiretroviral Agent Revenue by Region (2027-2032) & (US$ Million) Table 67. Global Antiretroviral Agent Revenue Market Share by Region (2021-2026) Table 68. Global Antiretroviral Agent Revenue Market Share by Region (2027-2032) Table 69. Boehringer Ingelheim Company Information Table 70. Boehringer Ingelheim Business Overview Table 71. Boehringer Ingelheim Antiretroviral Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Boehringer Ingelheim Antiretroviral Agent Product Portfolio Table 73. Boehringer Ingelheim Recent Development Table 74. Bristol-Myers Squibb Company Information Table 75. Bristol-Myers Squibb Business Overview Table 76. Bristol-Myers Squibb Antiretroviral Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Bristol-Myers Squibb Antiretroviral Agent Product Portfolio Table 78. Bristol-Myers Squibb Recent Development Table 79. Genentech Company Information Table 80. Genentech Business Overview Table 81. Genentech Antiretroviral Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Genentech Antiretroviral Agent Product Portfolio Table 83. Genentech Recent Development Table 84. Gilead Sciences Company Information Table 85. Gilead Sciences Business Overview Table 86. Gilead Sciences Antiretroviral Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Gilead Sciences Antiretroviral Agent Product Portfolio Table 88. Gilead Sciences Recent Development Table 89. Merck Sharp and Dohme Company Information Table 90. Merck Sharp and Dohme Business Overview Table 91. Merck Sharp and Dohme Antiretroviral Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Merck Sharp and Dohme Antiretroviral Agent Product Portfolio Table 93. Merck Sharp and Dohme Recent Development Table 94. ViiV Healthcare Company Information Table 95. ViiV Healthcare Business Overview Table 96. ViiV Healthcare Antiretroviral Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. ViiV Healthcare Antiretroviral Agent Product Portfolio Table 98. ViiV Healthcare Recent Development Table 99. AbbVie Company Information Table 100. AbbVie Business Overview Table 101. AbbVie Antiretroviral Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. AbbVie Antiretroviral Agent Product Portfolio Table 103. AbbVie Recent Development Table 104. GlaxoSmithKline Company Information Table 105. GlaxoSmithKline Business Overview Table 106. GlaxoSmithKline Antiretroviral Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. GlaxoSmithKline Antiretroviral Agent Product Portfolio Table 108. GlaxoSmithKline Recent Development Table 109. Pfizer Company Information Table 110. Pfizer Business Overview Table 111. Pfizer Antiretroviral Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Pfizer Antiretroviral Agent Product Portfolio Table 113. Pfizer Recent Development Table 114. Mylan Company Information Table 115. Mylan Business Overview Table 116. Mylan Antiretroviral Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Mylan Antiretroviral Agent Product Portfolio Table 118. Mylan Recent Development Table 119. Janssen Pharmaceuticals Company Information Table 120. Janssen Pharmaceuticals Business Overview Table 121. Janssen Pharmaceuticals Antiretroviral Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Janssen Pharmaceuticals Antiretroviral Agent Product Portfolio Table 123. Janssen Pharmaceuticals Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Antiretroviral Agent Distributors List Table 127. Antiretroviral Agent Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Antiretroviral Agent Product Image Figure 2. Global Antiretroviral Agent Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antiretroviral Agent Market Size (2021-2032) & (US$ Million) Figure 4. Global Antiretroviral Agent Sales (2021-2032) & (K Units) Figure 5. Global Antiretroviral Agent Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Antiretroviral Agent Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Fusion Inhibitors Image Figure 9. Entry Inhibitors—CCR5 Co-Receptor Antagonist Image Figure 10. Nucleoside Reverse Transcriptase Inhibitors Image Figure 11. Non-Nucleoside Reverse Transcriptase Inhibitors Image Figure 12. Protease Inhibitors Image Figure 13. HIV Integrase Strand Transfer Inhibitors Image Figure 14. Others Image Figure 15. Global Antiretroviral Agent Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Antiretroviral Agent Sales Market Share 2021 VS 2025 VS 2032 Figure 17. Global Antiretroviral Agent Sales Market Share by Type (2021-2032) Figure 18. Global Antiretroviral Agent Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Antiretroviral Agent Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Antiretroviral Agent Revenue Market Share by Type (2021-2032) Figure 21. Retail Pharmacies Image Figure 22. Online Pharmacies Image Figure 23. Hospital Pharmacies Image Figure 24. Others Image Figure 25. Global Antiretroviral Agent Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Antiretroviral Agent Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global Antiretroviral Agent Sales Market Share by Application (2021-2032) Figure 28. Global Antiretroviral Agent Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 29. Global Antiretroviral Agent Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global Antiretroviral Agent Revenue Market Share by Application (2021-2032) Figure 31. North America Antiretroviral Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 32. North America Antiretroviral Agent Sales Market Share by Country (2021-2032) Figure 33. U.S. Antiretroviral Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Canada Antiretroviral Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Mexico Antiretroviral Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Antiretroviral Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Europe Antiretroviral Agent Sales Market Share by Country (2021-2032) Figure 38. Germany Antiretroviral Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 39. France Antiretroviral Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 40. U.K. Antiretroviral Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Italy Antiretroviral Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Netherlands Antiretroviral Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Antiretroviral Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Asia Pacific Antiretroviral Agent Sales Market Share by Country (2021-2032) Figure 45. China Antiretroviral Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Japan Antiretroviral Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Korea Antiretroviral Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Southeast Asia Antiretroviral Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 49. India Antiretroviral Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Australia Antiretroviral Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Antiretroviral Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South America, Middle East and Africa Antiretroviral Agent Sales Market Share by Country (2021-2032) Figure 53. Brazil Antiretroviral Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 54. South Africa Antiretroviral Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Saudi Arabia Antiretroviral Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Turkey Antiretroviral Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Argentina Antiretroviral Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 58. UAE Antiretroviral Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Egypt Antiretroviral Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Chile Antiretroviral Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 61. Global Antiretroviral Agent Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global Antiretroviral Agent Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America Antiretroviral Agent Revenue (2021-2032) & (US$ Million) Figure 64. North America Antiretroviral Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Antiretroviral Agent Revenue (2021-2032) & (US$ Million) Figure 66. Europe Antiretroviral Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Antiretroviral Agent Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific Antiretroviral Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa Antiretroviral Agent Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa Antiretroviral Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. Antiretroviral Agent Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Antiretroviral Agent Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Fusion Inhibitors
  • Entry Inhibitors—CCR5 Co-Receptor Antagonist
  • Nucleoside Reverse Transcriptase Inhibitors
  • Non-Nucleoside Reverse Transcriptase Inhibitors
  • Protease Inhibitors
  • HIV Integrase Strand Transfer Inhibitors
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
  • Others
Companies covered
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Genentech
  • Gilead Sciences
  • Merck Sharp and Dohme
  • ViiV Healthcare
  • AbbVie
  • GlaxoSmithKline
  • Pfizer
  • Mylan
  • Janssen Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Antiretroviral Agent Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Antiretroviral Agent Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Antiretroviral Agent Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Antiretroviral Agent Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Antiretroviral Agent Market Dynamics
  1. 2.1 Antiretroviral Agent Industry Trends
  2. 2.2 Antiretroviral Agent Industry Drivers
  3. 2.3 Antiretroviral Agent Industry Opportunities and Challenges
  4. 2.4 Antiretroviral Agent Industry Restraints
3 Antiretroviral Agent Market by Manufacturers
  1. 3.1 Global Antiretroviral Agent Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Antiretroviral Agent Sales by Manufacturers (2021-2026)
  3. 3.3 Global Antiretroviral Agent Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Antiretroviral Agent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antiretroviral Agent Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Antiretroviral Agent Manufacturers, Product Type & Application
  7. 3.7 Global Antiretroviral Agent Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antiretroviral Agent Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antiretroviral Agent Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antiretroviral Agent Tier 1, Tier 2, and Tier 3
4 Antiretroviral Agent Market by Type
  1. 4.1 Antiretroviral Agent Type Introduction
  2. 4.1.1 Fusion Inhibitors
  3. 4.1.2 Entry Inhibitors—CCR5 Co-Receptor Antagonist
  4. 4.1.3 Nucleoside Reverse Transcriptase Inhibitors
  5. 4.1.4 Non-Nucleoside Reverse Transcriptase Inhibitors
  6. 4.1.5 Protease Inhibitors
  7. 4.1.6 HIV Integrase Strand Transfer Inhibitors
  8. 4.1.7 Others
  9. 4.2 Global Antiretroviral Agent Sales by Type
  10. 4.2.1 Global Antiretroviral Agent Sales by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Antiretroviral Agent Sales by Type (2021-2032)
  12. 4.2.3 Global Antiretroviral Agent Sales Market Share by Type (2021-2032)
  13. 4.3 Global Antiretroviral Agent Revenue by Type
  14. 4.3.1 Global Antiretroviral Agent Revenue by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Antiretroviral Agent Revenue by Type (2021-2032)
  16. 4.3.3 Global Antiretroviral Agent Revenue Market Share by Type (2021-2032)
5 Antiretroviral Agent Market by Application
  1. 5.1 Antiretroviral Agent Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.1.4 Others
  6. 5.2 Global Antiretroviral Agent Sales by Application
  7. 5.2.1 Global Antiretroviral Agent Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Antiretroviral Agent Sales by Application (2021-2032)
  9. 5.2.3 Global Antiretroviral Agent Sales Market Share by Application (2021-2032)
  10. 5.3 Global Antiretroviral Agent Revenue by Application
  11. 5.3.1 Global Antiretroviral Agent Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Antiretroviral Agent Revenue by Application (2021-2032)
  13. 5.3.3 Global Antiretroviral Agent Revenue Market Share by Application (2021-2032)
6 Global Antiretroviral Agent Sales by Region
  1. 6.1 Global Antiretroviral Agent Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antiretroviral Agent Sales by Region (2021-2032)
  3. 6.2.1 Global Antiretroviral Agent Sales by Region (2021-2026)
  4. 6.2.2 Global Antiretroviral Agent Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Antiretroviral Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Antiretroviral Agent Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Antiretroviral Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Antiretroviral Agent Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Antiretroviral Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Antiretroviral Agent Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Antiretroviral Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Antiretroviral Agent Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Antiretroviral Agent Revenue by Region
  1. 7.1 Global Antiretroviral Agent Revenue by Region
  2. 7.1.1 Global Antiretroviral Agent Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Antiretroviral Agent Revenue by Region (2021-2026)
  4. 7.1.3 Global Antiretroviral Agent Revenue by Region (2027-2032)
  5. 7.1.4 Global Antiretroviral Agent Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Antiretroviral Agent Revenue (2021-2032)
  8. 7.2.2 North America Antiretroviral Agent Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Antiretroviral Agent Revenue (2021-2032)
  11. 7.3.2 Europe Antiretroviral Agent Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Antiretroviral Agent Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Antiretroviral Agent Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Antiretroviral Agent Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Antiretroviral Agent Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim
  2. 8.1.1 Boehringer Ingelheim Company Information
  3. 8.1.2 Boehringer Ingelheim Business Overview
  4. 8.1.3 Boehringer Ingelheim Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim Antiretroviral Agent Product Portfolio
  6. 8.1.5 Boehringer Ingelheim Recent Developments
  7. 8.2 Bristol-Myers Squibb
  8. 8.2.1 Bristol-Myers Squibb Company Information
  9. 8.2.2 Bristol-Myers Squibb Business Overview
  10. 8.2.3 Bristol-Myers Squibb Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bristol-Myers Squibb Antiretroviral Agent Product Portfolio
  12. 8.2.5 Bristol-Myers Squibb Recent Developments
  13. 8.3 Genentech
  14. 8.3.1 Genentech Company Information
  15. 8.3.2 Genentech Business Overview
  16. 8.3.3 Genentech Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Genentech Antiretroviral Agent Product Portfolio
  18. 8.3.5 Genentech Recent Developments
  19. 8.4 Gilead Sciences
  20. 8.4.1 Gilead Sciences Company Information
  21. 8.4.2 Gilead Sciences Business Overview
  22. 8.4.3 Gilead Sciences Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Gilead Sciences Antiretroviral Agent Product Portfolio
  24. 8.4.5 Gilead Sciences Recent Developments
  25. 8.5 Merck Sharp and Dohme
  26. 8.5.1 Merck Sharp and Dohme Company Information
  27. 8.5.2 Merck Sharp and Dohme Business Overview
  28. 8.5.3 Merck Sharp and Dohme Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck Sharp and Dohme Antiretroviral Agent Product Portfolio
  30. 8.5.5 Merck Sharp and Dohme Recent Developments
  31. 8.6 ViiV Healthcare
  32. 8.6.1 ViiV Healthcare Company Information
  33. 8.6.2 ViiV Healthcare Business Overview
  34. 8.6.3 ViiV Healthcare Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 ViiV Healthcare Antiretroviral Agent Product Portfolio
  36. 8.6.5 ViiV Healthcare Recent Developments
  37. 8.7 AbbVie
  38. 8.7.1 AbbVie Company Information
  39. 8.7.2 AbbVie Business Overview
  40. 8.7.3 AbbVie Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 AbbVie Antiretroviral Agent Product Portfolio
  42. 8.7.5 AbbVie Recent Developments
  43. 8.8 GlaxoSmithKline
  44. 8.8.1 GlaxoSmithKline Company Information
  45. 8.8.2 GlaxoSmithKline Business Overview
  46. 8.8.3 GlaxoSmithKline Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GlaxoSmithKline Antiretroviral Agent Product Portfolio
  48. 8.8.5 GlaxoSmithKline Recent Developments
  49. 8.9 Pfizer
  50. 8.9.1 Pfizer Company Information
  51. 8.9.2 Pfizer Business Overview
  52. 8.9.3 Pfizer Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pfizer Antiretroviral Agent Product Portfolio
  54. 8.9.5 Pfizer Recent Developments
  55. 8.10 Mylan
  56. 8.10.1 Mylan Company Information
  57. 8.10.2 Mylan Business Overview
  58. 8.10.3 Mylan Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Mylan Antiretroviral Agent Product Portfolio
  60. 8.10.5 Mylan Recent Developments
  61. 8.11 Janssen Pharmaceuticals
  62. 8.11.1 Janssen Pharmaceuticals Company Information
  63. 8.11.2 Janssen Pharmaceuticals Business Overview
  64. 8.11.3 Janssen Pharmaceuticals Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Janssen Pharmaceuticals Antiretroviral Agent Product Portfolio
  66. 8.11.5 Janssen Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antiretroviral Agent Value Chain Analysis
  2. 9.1.1 Antiretroviral Agent Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antiretroviral Agent Production Mode & Process
  6. 9.2 Antiretroviral Agent Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antiretroviral Agent Distributors
  9. 9.2.3 Antiretroviral Agent Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst